Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.
Mary, yes - I thought I had poster a later note but must have hit the wrong button.... Merck's IBF 1a is called Rebif and is the one used for MS therapy. It is given by injection i.e. sc. Faron's is intravenous. Merck donated to the INSERM discovery trial and 290,000 units to the WHO Solidarity trial. Wish I could find the same info for Traumakine.
Quesera, sorry, I jumped in too quickly. The trial referred in the article is the Discovery trial sponsored by the French health research Agency INSERM. WHO Solidarity is a different trial but similar therapy options.
An article published in Pharmaceuticals on 10th April notes that IFB 1a when administered with the HIV drugs will be delivered sc i.e. by injection (see section 4.3) - https://www.google.com/url?sa=t&source=web&rct=j&url=https://www.mdpi.com/1424-8247/13/4/65/pdf&ved=2ahUKEwi36J342rjqAhVRQxUIHdrcAQ8QFjAEegQIBRAB&usg=AOvVaw05RutXEbtHMgDv0nQiVq9O&cshid=1594041462384
Agreed Dan, it would make things a lot clearer. I've only just got used to a or b......
Dan, it works on both.
"Interferon beta-1a is a cytokine in the interferon family used to treat multiple sclerosis. It is produced by mammalian cells, while interferon beta-1b is produced in modified E. coli. Some claims have been made that Interferons produce about an 18–38% reduction in the rate of MS relapses. "
There was some confusion over the weekend as to whether IFB was completely dropped with the HIV drugs or whether it was now be used in the WHO trial eiher alone or in combo with remdesivir. If it is one of the last two men left standing then these prices are just a glitch. If not, ???
Too many years of his obsessive ranting ruined what used to be a moderate and useful BB. And always difficult to tell if his fawning acolytes were realling adoring followers or just multiple incarnations of the holy one. Having said that I am still banking on his £10 by the end of the month being bang on the money.
Is asking £10 a bit optimistic then?
Hi Dibs, I got massively savaged by the same dog. Completely taken in by his friendly face and tail wagging. Been very cynical about RNS and video PR interviews ever since. Bought some here a long time ago when it was pennies and not played with it since then. Just keeping fingers crossed.
Strictly, relax mate. £10 by the end of the month. BOOM!
A public company must hold an AGM within six months from the end of its financial accounting period (or such earlier date as may be specified in its articles of association (Articles)), following which, the company’s annual accounts (which must be laid before the meeting) must be filed within the same time period.
Thanks Mathias,
The active pharmaceutical ingredient in Traumakine® is recombinant human IFN beta-1a.
Unfortunately, Professor Hung seems to be backing IFN Beta-1b.
I do not think they are the same but could well be my misunderstanding
Nolupus, I wasn't talking about the management or company style; at least not intentionally. I was referring to the oh so confident twitterati rampers who "knew" that the Immupharma results were good - at least until the trial was unblinded and the results published. I filter out the ramping experts here and, more especially, on Faron. Saves oceans of screen space and makes the BB much more interesting. On the Faron board some believe that if the MD looks as though he is half smiling in Proactive interviews it is a sure sign of billion dollar success. One decent burp would probably be worth trillions.